Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
Top Cited Papers
- 1 March 2012
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 12 (3) , 240-248
- https://doi.org/10.1016/s1473-3099(11)70318-8
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) InfectionThe Journal of Infectious Diseases, 2011
- Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients—North Carolina, 2009The Journal of Infectious Diseases, 2011
- Frequency of Drug-resistant Viruses and Virus Shedding in Pediatric Influenza Patients Treated With Neuraminidase InhibitorsClinical Infectious Diseases, 2011
- MultiDrug-Resistant 2009 Pandemic Influenza A(H1N1) Viruses Maintain Fitness and Transmissibility in FerretsThe Journal of Infectious Diseases, 2011
- Evidence of Person-to-Person Transmission of Oseltamivir-Resistant Pandemic Influenza A(H1N1) 2009 Virus in a Hematology UnitThe Journal of Infectious Diseases, 2011
- Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition AssaysAntimicrobial Agents and Chemotherapy, 2010
- Minority Variants of Drug‐Resistant HIVThe Journal of Infectious Diseases, 2010
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir ResistanceScience, 2010
- Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by PyrosequencingAntimicrobial Agents and Chemotherapy, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009